You have 9 free searches left this month | for more free features.

City

Vancouver (1)

Condition

Multiple Sclerosis (2)

Type 1 Diabetes Mellitus (1)

Overall Status

Not yet recruiting (2)

Recruiting (1)

Sign in for free

Phase

phase 3 (2)

phase 2 (1)

Sponsor

Sanofi (3)

Collaborator

Intervention

frexalimab (3)

mri contrast-enhancing agents (2)

placebo (2)

activated charcoal (1)

cholestyramine (1)

insulin (1)

placebo infusion (1)

placebo tablet (1)

teriflunomide (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (3)

Study Type

Interventional (3)

frexalimab

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Multiple Sclerosis Trial (Frexalimab, Placebo, MRI contrast-enhancing agents)

Not yet recruiting

Multiple Sclerosis

Frexalimab
+2 more

(no location specified)

Nov 15, 2023

Multiple Sclerosis Trial (Frexalimab, Teriflunomide, Placebo infusion)

Not yet recruiting

Multiple Sclerosis

Frexalimab
+6 more

(no location specified)

Nov 15, 2023

Type 1 Diabetes Trial in Vancouver (Frexalimab, Placebo, Insulin)

Recruiting

Type 1 Diabetes Mellitus

Frexalimab
+2 more

Vancouver, British Columbia, Canada

Investigational Site Number : 1240001

Oct 31, 2023